Compare Immunovant Inc. Common Stock (IMVT) vs Marex Group Limited Ordinary Shares (MRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Marex Group Limited Ordinary Shares — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while Marex Group Limited Ordinary Shares trades at $71.17 (market cap $5.18B). The key difference: Immunovant Inc. Common Stock is the larger of the two by market cap, and Marex Group Limited Ordinary Shares pays a 0.89% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Marex Group Limited Ordinary Shares for 0 Days on average.
| IMVT | MRX | |
|---|---|---|
Market Cap | $6.62B | $5.18B |
Volume | 1,131,364 | 665,047 |
Sector | Health | Financials |
52-Week High | $44.96 | $78.27 |
52-Week Low | $17.03 | $29.92 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.72B | $8.26B |
Dividend Yield | — | 0.89% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Marex Group Limited Ordinary Shares
Marex Group provides financial services across commodities, financial markets, and corporate clients. Its services include clearing, agency and execution, market making, hedging, and securities services.
Read more on MRX →
